changing from semaglutide to zepbound Impact of the CVS GLP-1 formulary change: Trends in switching changing from semaglutide to zepbound

Pharmacokinetics: Long acting (half life: ~1 week ) Ozempic & Wegovy : subcutaneous pen injections weekly a more favorable option for some patients compared to daily injections of short acting analogs semaglutide has a high bioavailability of ~89% when injected s.c

[1] [2] Using improperly stored GLP-1 medication may result in inadequate glycemic control for patients with type 2 diabetes, potentially leading to hyperglycemia

rapid weight loss on body composition and RMR: a systematic review and meta-analysis

Mounjaro, on the other hand, is unique in that it targets metabolism instead of hunger signals, promoting weight loss by increasing the rate at which the body burns calories

The Anticoagulant Clinic should call you if you take a blood thinner such as Warfarin/Coumadin, Eliquis/Apixaban, Xarelto/Rivaroxaban or Pradaxa/Dabigatran

For patients whose primary reason for medication is weight loss rather than diabetes, Wegovy is typically the target formulation